We report four cases of niacin-induced hepatotoxicity. All four patien
ts were using sustained-release niacin preparations. When they stopped
taking niacin, symptoms and laboratory abnormalities resolved. Two of
the patients had focal fatty infiltration of the liver on imaging stu
dies, a presentation of niacin hepatotoxicity not previously described
. One patient had a coagulopathy even though aminotransferase levels w
ere only mildly elevated. We recommend that patients using sustained-r
elease preparations of niacin have periodic monitoring of liver enzyme
s and that the preparation be discontinued if any abnormalities develo
p.